Irrimax Corporation
Tanya Eberle is a seasoned professional in regulatory affairs with extensive experience in the medical and biotechnology industries. Currently serving as Vice President of Regulatory Affairs at Irrimax Corporation since July 2021, Tanya has held several key positions including Senior Director of Regulatory and Quality Affairs at both Cartiva, Inc. and Wright Medical. Previous roles also include Director of Regulatory Affairs at CSSi LifeSciences and Carticept Medical, as well as regulatory management positions at SANUWAVE, Inc. and CryoLife, Inc. Tanya Eberle holds a Bachelor of Science degree in Biology from Kennesaw State University.
This person is not in any teams
Irrimax Corporation
Irrimax Corporation is focused on treating and preventing infections, reducing healthcare costs, improving patient outcomes and increasing the safety of healthcare professionals.Innovation Technologies, Inc., parent company to Irrimax Corporation, holds the rights to US and worldwide patents that provide broad protection for the use oflow-concentration CHG (1% or less) technology. The company’s flagship product, Irrisept, is jet lavage containing low concentration Chlorhexidine Gluconate (CHG) 0.05% in sterile water for irrigation.Irrimax has attracted experts in the fields of product development, clinical research, manufacturing and distribution. Their management team is committed to leading the organization according to high standards of integrity and accountability. Irrimax Corporation is focused on driving innovation and improving patient outcomes.